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Abstract
Carboxymethyl guar gum, capable of forming spherical cross-linked beads when exposed to Ca++ and Ba++, has been prepared. As a model protein drug, BSA has been encapsulated in barium chloride cross-linked CMGG beads and its release in vitro in simulated gastric and intestinal buffers was investigated. It was found that BaCl2 crosslinked beads protect the protein from low pH conditions and deliver it completely in simulated intestinal fluid. 
Complex coacervation of gelatin with sodium carboxymethyl guar gum was studied. Both the coacervate yield and absorbance studied suggest that as the amount of CMGG increases in the colloids, the pH at which maximum coacervation happens is reduced. However, it was shown that effective coacervation can be realized over the pH range of 2.5 to 4.0 by choosing appropriate colloid ratio. The system was successfully used to microencapsulate clove oil and sulfamethoxazole as model liquid and solid core materials. 
Several metal chlorides were shown to be able to cross-link NaCMGG in to acid insensitive beads. Trivalent metal ions like aluminum and iron do so at much lower concentrations than other divalent metal salts tried. Trivalent metal salts also provide more drug retention while the beads are prepared. Except for CdCl2 cross-linked beads which lost some of its loaded drug, all metal salts tried in the study provided protection to the loaded protein from the acidic environs of stomach. As compared to divalent metal salts, trivalent metal salt cross-linked beads released the protein more slowly in simulated intestinal fluids. By judicious selection of metal salt used and its concentration, it should be possible to engineer a particularly desirable release profile in a formulation. 
  	 


